Park Square Places Sue Bruhn as CEO of Tiaki Therapeutics
Tiaki Therapeutics has appointed Suzanne Bruhn as CEO. Bruhn, a serial biotech CEO, arrives at Tiaki shortly after the Alzheimer’s...
Tiaki Therapeutics has appointed Suzanne Bruhn as CEO. Bruhn, a serial biotech CEO, arrives at Tiaki shortly after the Alzheimer’s...
The Park Square team is thrilled to support Deep Genomics and their unique, AI-driven approach to discovering and developing genetic...
Park Square is pleased to announce the placement of Michael Cox as Vice President, Clinical Development at Puma Biotechnology. Puma...
As a free user, you can like posts.
To repost this post to your own Passle blog, you will need to upgrade your account.
For plans and pricing, please contact our sales team at sales@passle.net